Two House lawmakers seek biotech investments to counter Chinanews2025-07-24T17:49:36+00:00July 24th, 2025|Endpoints News|
Rocket cuts 30% of staff as it plots path forward for gene therapiesnews2025-07-24T15:24:25+00:00July 24th, 2025|Endpoints News|
Sarepta would have to conduct new studies to get back on market, FDA official saysnews2025-07-24T15:17:46+00:00July 24th, 2025|Endpoints News|
AstraZeneca’s self-administered myasthenia gravis drug clears Phase 3 trialnews2025-07-24T11:38:53+00:00July 24th, 2025|Endpoints News|
Roche looks at direct-to-patient sales in the US, drops preclinical obesity drug from Carmot buynews2025-07-24T10:55:20+00:00July 24th, 2025|Endpoints News|
FDA delays review date for GSK’s multiple myeloma drug Blenrepnews2025-07-23T16:42:28+00:00July 23rd, 2025|Endpoints News|
Roche halts Elevidys shipments in six countries as Europe mulls approvalnews2025-07-23T15:27:54+00:00July 23rd, 2025|Endpoints News|
Abivax shares up over 400% as ulcerative colitis drug scores two Phase 3 winsnews2025-07-23T11:08:31+00:00July 23rd, 2025|Endpoints News|
Apnimed’s sleep apnea pill clears second Phase 3, setting up FDA filingnews2025-07-23T10:00:51+00:00July 23rd, 2025|Endpoints News|
CROs show signs of recovery but warn the future of R&D funding is uncertainnews2025-07-22T15:33:41+00:00July 22nd, 2025|Endpoints News|
